RCAG
BIIB icon

Rehmann Capital Advisory Group’s Biogen BIIB Stock Holding History

Rehmann Capital Advisory Group’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$214K Buy
+1,165
New +$215K 0.01% 632
2020
Q4 		– Sell
-740
Closed -$210K – 485
2020
Q3 		$210K Buy
+740
New +$206K 0.03% 397
2019
Q3 		$146K Buy
626
+26
+4% +$6.05K 0.02% 371
2019
Q2 		$140K Buy
600
+26
+5% +$6K 0.02% 510
2019
Q1 		$136K Sell
574
-49
-8% -$15.4K 0.02% 508
2018
Q4 		$187K Sell
623
-18
-3% -$5.74K 0.03% 258
2018
Q3 		$226K Buy
641
+7
+1% +$2.41K 0.03% 372
2018
Q2 		$184K Sell
634
-24
-4% -$6.75K 0.03% 398
2018
Q1 		$180K Buy
658
+5
+0.8% +$1.55K 0.03% 397
2017
Q4 		$208K Buy
653
+3
+0.5% +$962 0.04% 365
2017
Q3 		$204K Buy
+650
New +$192K 0.04% 359
2016
Q4 		– Sell
-703
Closed -$220K – 384
2016
Q3 		$220K Sell
703
-183
-21% -$54.2K 0.04% 324
2016
Q2 		$214K Buy
886
+115
+15% +$30.3K 0.04% 336
2016
Q1 		$201K Sell
771
-469
-38% -$124K 0.04% 335
2015
Q4 		$380K Sell
1,240
-65
-5% -$18.7K 0.08% 192
2015
Q3 		$381K Sell
1,305
-174
-12% -$57.5K 0.09% 184
2015
Q2 		$597K Buy
1,479
+5
+0.3% +$2.01K 0.14% 134
2015
Q1 		$622K Buy
1,474
+66
+5% +$26K 0.14% 136
2014
Q4 		$478K Sell
1,408
-1
-0.1% -$324 0.11% 158
2014
Q3 		$466K Buy
1,409
+22
+2% +$7.25K 0.11% 156
2014
Q2 		$437K Buy
1,387
+202
+17% +$60.8K 0.1% 163
2014
Q1 		$362K Buy
1,185
+34
+3% +$10.8K 0.1% 169
2013
Q4 		$322K Buy
1,151
+132
+13% +$34.1K 0.1% 190
2013
Q3 		$245K Buy
+1,019
New +$228K 0.08% 220

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Rehmann Capital Advisory Group's BIIB Position: Q1 2026 in Review

Rehmann Capital Advisory Group opened a new position in Biogen (BIIB) in Q1 2026: 1,165 shares worth $214K. The stake represents 0.01% of the portfolio and ranks #632 among its holdings. This is a return to the name: Rehmann Capital Advisory Group previously reported a position in BIIB as recently as Q3 2020.

Rehmann Capital Advisory Group first reported a position in BIIB in Q3 2013 and has held it in 24 quarters since. The position peaked at $622K in Q1 2015. 1,004 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Rehmann Capital Advisory Group held 1,165 shares of Biogen worth $214K as of Q1 2026.
  • Biogen was a new Rehmann Capital Advisory Group position in Q1 2026.
  • Biogen made up 0.01% of Rehmann Capital Advisory Group's portfolio in Q1 2026, its #632 holding.
  • Rehmann Capital Advisory Group first reported a position in Biogen in Q3 2013 and has held it in 24 quarters since.
  • Rehmann Capital Advisory Group's Biogen position peaked at $622K in Q1 2015.
  • 1,004 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Rehmann Capital Advisory Group's 13F filing for Q1 2026, filed 15 May 2026.